What now? i had most of my money in CLSN - and then after that imploded put it into ZIOP figuring i'd get a quick, near term pop back to even with the data readout. What do i do now? Sell? My wife was mad about CLSN - now this.
1.Sell 50% now. 2.Keep 50% in hard cash. buy flowers to your lady - tell her the truth - and a week holidays
3. with the other 50% invest in another biotech. not on the nasdaq, too high to easy to short. OTC better.
do your DD on Pvct - Provectus Pharma. Good luck
Predicted probability for trial success was around 60%............chances of winning lottery are not as good. I think he should take a loan, pay interest and try his luck by investing in an another Pharma stock.............there are many out there, and the poor guy can't be unlucky all the time! If he does wish to take a loan then he should forget about stock trading.
biotech working in cancer are extremely dangerous, especially for small bio. Look at EXEL, NAVB (still cheap), o others working in different fields DSCO or AFFY (tis last with moderation). Wait for ZIOP next dilution, then, but only then buy moderately. Avoid at the moment THLD, it is also risky at this price, Moderately buy only approx at 4-4,2$, no more. Probably the majority of these stocks are not so appealing as ZIOP recently, but are more safe, at least now.
now now - just looking for new ideas. can't be in biotech w/o taking it on the chin, right? Even a billionaire investor got caught up in ZIOP. i'm thinking that biotechs having one drug candidate are a bit much but i still like SRPT even though its near term prospects are riding on one drug but at least i know it works. For a broader pipeline, i'm thinking ARRY and MACK.
You need to buy a stock with better odds.
There's lots of risk waiting for P3 trial data.
If the data is successful, then you have to wait for the NDA filing.
Then there is risk with the NDA panel followed by the PDUFA opinion risk.
Check out TTNP.
It has had a successful P3 trial.
It has had a successful P3 confirmatory trial.
It has had a successful long term trial.
It has had a FDA panel vote 10 - 4 in favor of approval.
The FDA granted Priority Review so the PDUFA date is in April.
Probuphine is a 6 month implant to treat opiod addiction.
The US market is $1.5 billion and growing.
TTNP's market cap is below $150M.
A milestone payment of $50M will be received upon approval next month.